Significant Ownership of ROCHE FINANCE LTD
- Signature - Title
- /s/ Carole Nuechterlein - Carole Nuechterlein, Authorized Signatory
- Location
- Basel Switzerland, Switzerland
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by ROCHE FINANCE LTD.
Follow Filing Activity
Follow ROCHE FINANCE LTD and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of ROCHE FINANCE LTD
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 6.9% | $23,019,270 | 2,569,115 | Roche Finance Ltd | 31 Dec 2024 |
Schedules 13D/G Reported by ROCHE FINANCE LTD:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.